Pyrrolopyrimidine Derivatives Used As HSP90 Inhibitors
    1.
    发明申请
    Pyrrolopyrimidine Derivatives Used As HSP90 Inhibitors 审中-公开
    用作HSP90抑制剂的吡咯并嘧啶衍生物

    公开(公告)号:US20090163490A1

    公开(公告)日:2009-06-25

    申请号:US12282526

    申请日:2007-03-09

    CPC分类号: C07D487/04

    摘要: Compounds of formula (I) have HSP90 inhibitory activity and are therefore useful in the treatment of, inter alia, cancer: Formula (I) wherein Ri is hydrogen, fluoro, chloro, bromo, or a radical of formula -X-Alk1-(Z)m-(Alk2)n-Q wherein X is —O—, —S— —S(O)—, SO2—, or —NH—, Z is —O—, —S—, —(C═O)—, —(C═S)—, —S(O)—, —SO2—, —NRA—, or, in either orientation —C(═O)O—, —C(═O)NRA—, —C(═S)NRA—, —SO2NRA—, —NRAC(═O)—, or —NRASO2— wherein RA is hydrogen or C1-C6 alkyl AIk1 and AIk2 are optionally substituted divalent C1-C3 alkylene or C2-C3 alkenylene radicals, m, n and p are independently 0 or 1, and Q is hydrogen or an optionally substituted carbocyclic or heterocyclic radical; R2 is a radical of formula —(Ar1)p-(Alk1)q-(Z)r-(Alk2)s-Q wherein Ar1 is an optionally substituted aryl or heteroaryl radical, Alk1, Alk2, Z, and Q are as defined above, and p, q, r and s are independently 0 or 1; and R3 is cyano (—CN), fluoro, chloro, bromo, methyl in which in which one or more hydrogen atoms are optionally replaced by fluorine atoms, ethyl in which in which one or more hydrogen atoms are optionally replaced by fluorine atoms, cyclopropyl, —OH, —CH2OH, —C(O)NH2, —C(O)CH3, Or —NH2.

    摘要翻译: 式(I)化合物具有HSP90抑制活性,因此可用于治疗尤其是癌症:式(I)其中R 1是氢,氟,氯,溴或式-X-Alk1-( Z)m-(Alk2)nQ其中X是-O - , - S-S(O) - ,SO2-或-NH-,Z是-O - , - S-, -​​ (CO) ( - ) - , - ( - O - ) - , - ( - O - ) - , - ( - - , - SO 2 -NRA - , - NRAC(-O) - 或-NRASO 2 - ,其中RA为氢或C 1 -C 6烷基,Alk 1和Alk 2为任选取代的二价C 1 -C 3亚烷基或C 2 -C 3亚烯基,m,n和p 独立地为0或1,并且Q为氢或任选取代的碳环或杂环基; R2是式 - (Ar1)p-(Alk1)q-(Z)r-(Alk2)sQ的基团,其中Ar1是任选取代的芳基或杂芳基,Alk1,Alk2,Z和Q如上定义, 和p,q,r和s独立地为0或1; 并且R 3是氰基(-CN),氟,氯,溴,其中一个或多个氢原子任选被氟原子取代的甲基,其中一个或多个氢原子任选被氟原子取代的乙基,环丙基 ,-OH,-CH 2 OH,-C(O)NH 2,-C(O)CH 3或-NH 2。